Acquired Hemophilia
📧 Sign up to get email alerts when something new happens for Acquired Hemophilia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: Trial of Acquired Haemophilia With Steroid Combined With Cyclophosphamide Versus Steroid Combined With Rituximab [Phase 4]
A Phase 4 trial comparing steroid plus cyclophosphamide versus steroid plus rituximab for acquired hemophilia A has completed.
-
CLINICAL_TRIALS research · 2025-11-05Clinical Trial Update: Emicizumab in Patients With Acquired Hemophilia A [Phase 2]
A Phase 2 clinical trial evaluating emicizumab for acquired hemophilia A is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-08-12Clinical Trial Update: A Study of OBIZUR in Adults With Acquired Hemophilia A (AHA) in South Korea
Clinical trial update for OBIZUR in adults with Acquired Hemophilia A in South Korea shows the study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-08-05Clinical Trial Update: An Exploratory Study of Cluster of Differentiation 38 (CD38) Monoclonal Antibody Combined Corticosteroid in Acquired Hemophilia A [Phase 4]
A Phase 4 exploratory clinical trial evaluating a CD38 monoclonal antibody plus corticosteroid for acquired hemophilia is currently recruiti…
-
CLINICAL_TRIALS research · 2025-06-04Clinical Trial Update: A Survey of Susoctocog Alfa (Genetical Recombination) in Participants With Acquired Haemophilia A
Takeda is conducting a recruiting trial to evaluate susoctocog alfa in participants with acquired hemophilia A. This entry shows the study s…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-12-02Clinical Trial Update: Study of TAK-672 in Participants With Acquired Hemophilia A [Phase 2, Phase 3]
Takeda's TAK-672 study in Acquired Hemophilia A (Phase 2/3) has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-11-23Clinical Trial Update: Study to Evaluate Rituximab and Bortezomib in Patients With Newly Diagnosed Acquired Hemophilia A [Phase 2]
A Phase 2 clinical trial evaluating rituximab and bortezomib for newly diagnosed acquired hemophilia A.
-
CLINICAL_TRIALS trial_result · 2017-02-10Clinical Trial Update: Trial of Rituximab Versus Oral Cyclophosphamide to Eradicate or Suppress Autoimmune Anti-Factor VIII Antibodies in Acquired Hemophilia A [Phase 2, Phase 3]
A Phase 2/3 trial comparing Rituximab to oral cyclophosphamide for eradicating or suppressing autoimmune anti-Factor VIII antibodies in acqu…
-
CLINICAL_TRIALS trial_result · 2016-12-07Clinical Trial Update: Observational Study on the Efficacy and Safety of NovoSeven® During "Real-life" Usage in Germany
Completed observational study in Germany evaluating the real-world efficacy and safety of NovoSeven (recombinant activated factor VII) for c…
-
CLINICAL_TRIALS trial_result · 2015-12-21Clinical Trial Update: Study of Modified Recombinant Factor VIII (OBI-1) in Subjects With Acquired Hemophilia A [Phase 2, Phase 3]
Phase 2/Phase 3 study of a modified recombinant Factor VIII (OBI-1) in acquired Hemophilia A has completed with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2013-06-18Clinical Trial Update: Prospective Clinical and Biological Follow-up of Acquired Haemophilia : SACHA Study
This clinical trial update reports prospective clinical and biological follow-up of patients with acquired hemophilia in the SACHA study (NC…